Podcast Episodes
Back to SearchCAR T-cell therapy in ALL: trial updates, novel approaches, & real-world outcomes
Episode 281
CAR T-cell therapy has become an established treatment for several hematological malignancies, including acute lymphoblastic leukemia (ALL), and has …
1 year, 7 months ago
Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more!
Today’s podcast features a discussion with experts Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, and Ashutosh Wechalek…
1 year, 7 months ago
Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more!
Episode 280
Today's podcast features a discussion with experts Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, and Ashutosh Wechalek…
1 year, 7 months ago
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia
This episode of the VJHemOnc podcast covers updates in non-malignant hematological diseases from the 66th American Society of Hematology (ASH) Annual…
1 year, 7 months ago
Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia
Episode 279
This episode of the VJHemOnc podcast covers updates in non-malignant hematological diseases from the 66th American Society of Hematology (ASH) Annual…
1 year, 7 months ago
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025
This podcast brings you exclusive updates on multiple myeloma from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held …
1 year, 7 months ago
Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025
Episode 278
This podcast brings you exclusive updates on multiple myeloma from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held …
1 year, 7 months ago
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML
In this podcast, we bring you exclusive updates in acute myeloid leukemia (AML) from the 66th American Society of Hematology (ASH) Annual Meeting and…
1 year, 8 months ago
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML
Episode 277
In this podcast, we bring you exclusive updates on acute myeloid leukemia (AML) from the 66th American Society of Hematology (ASH) Annual Meeting and…
1 year, 8 months ago
Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more!
This podcast episode covers highlights in myeloproliferative neoplasms (MPNs) from the 66th American Society of Hematology (ASH) Annual Meeting and E…
1 year, 8 months ago